115-33-3
115-33-3
Chemical Structure
Oxyphenisatin acetate
- CAS No.: 115-33-3
- Formula:C24H19NO5
- Molecular Weight:401.41
IUPAC Name: (2-oxoindoline-3,3-diyl)bis(4,1-phenylene) diacetate
InChIKey: PHPUXYRXPHEJDF-UHFFFAOYSA-N
SMILES: O=C1NC2=C(C=CC=C2)C1(C3=CC=C(OC(C)=O)C=C3)C4=CC=C(OC(C)=O)C=C4
Biological Activity: Oxyphenisatin acetate, the pro-agent of oxyphenisatin, is used to be a laxative.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Oxyphenisatin acetate | 98.30% | Oxyphenisatin acetate, the pro-agent of oxyphenisatin, is used to be a laxative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oxyphenisatin acetate (Standard) | ≥98% | Oxyphenisatin acetate (Standard) is the analytical standard of Oxyphenisatin acetate. This product is intended for research and analytical applications. Oxyphenisatin acetate, the pro-agent of oxyphenisatin, is used to be a laxative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bisoxatin acetate | 98.41% | Bisoxatin (WY 8138; DB09219) acetate is a laxative agent. Bisoxatin acetate is a stimulant for intestinal peristalsis and has the potential for the research of constipation disorder. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sulisatin | Sulisatin (DAN-603) is an anionic laxative that is hydrolyzed to diphenolic derivatives by bacterial aryl sulfate sulfohydrolases in the colon during oral administration. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sulisatin disodium | Sulisatin (DAN-603) disodium is an anionic diarrhea-promoting compound. During oral administration, Sulisatin disodium is hydrolyzed to diphenolic derivatives by bacterial aryl sulfate sulfohydrolases in the colon. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
BHPI | 98.0% | BHPI is a nuclear receptor ERα inhibitor. BHPI activates PLCγ and UPR. BHPI has antitumor activity against breast, endometrial, and ovarian cancers. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
ErSO | 99.92% | ErSO is a selective anticipatory unfolded protein response (a-UPR) activator. ErSO acts through ERα to elicit strong and sustained cytotoxic activation of the a-UPR. ErSO can be used for the research of cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-ErSO | (±)-ErSO is the racemate of ErSO. ErSO is a selective anticipatory unfolded protein response (a-UPR) activator. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(S)-ErSO | 99.40% | (S)-ErSO is the dextrorotatory enantiomer of ErSO. (S)-ErSO is inactive in MCF-7 cells (from patent WO2020009958A1, compound (s)-105). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
TAS-301 (Standard) | ≥98% | TAS-301 (Standard) is the analytical standard of TAS-301. This product is intended for research and analytical applications. TAS-301 is an inhibitor of smooth muscle cell migration and proliferation, and inhibits PKC activation induced by PDGF. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bisacodyl (Standard) | ≥98% | Bisacodyl (Standard) is the analytical standard of Bisacodyl. This product is intended for research and analytical applications. Bisacodyl is a stimulant laxative agent that works directly on the colon to produce a bowel movement. Bisacodyl increases the secretion of PGE2 by direct activation of colon macrophages. PGE2 acts as a paracrine factor and decreases the expression of AQP3 in the colon, which inhibits water transfer from the luminal to the vascular side and leads to a laxative effect. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oxyphenisatine (Standard) | ≥98% | Oxyphenisatine (Standard) is the analytical standard of Oxyphenisatine. This product is intended for research and analytical applications. Oxyphenisatine (Oxyphenisatin) is a laxative. Oxyphenisatin acetate is the pro-agent of oxyphenisatin with anticancer activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
